0.99
1.27%
0.0126
Ocean Biomedical Inc (OCEA) 最新ニュース
Dr. Chirinjeev Kathuria - Smart Business Dealmakers
Everything you need to know about Zenas BioPharma’s IPO - AlphaStreet
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms - ForexTV.com
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent - GlobeNewswire
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms - Morningstar
Ocean Biomedical, Inc. Announces Receipt of Notice from - GlobeNewswire
Ocean Biomedical Faces Nasdaq Compliance Challenges - TipRanks
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - StockTitan
Ocean Biomedical (NASDAQ: OCEA) Research Summary - AlphaStreet
Ocean Biomedical Inc. (OCEA) Stock: Navigating a Year of Volatility - The InvestChronicle
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.16% - MSN
Ocean Biomedical secures additional financing, issues equity - Investing.com
Financial Health Check: Examining Ocean Biomedical Inc. (OCEA)'s Key Ratios – DWinneX - The Dwinnex
Ocean Biomedical Inc. (OCEA) is a good investment, but the stock may be overvalued – US Post News - US Post News
Everything you need to know about OS Therapies’ upcoming IPO - AlphaStreet
3-Month SOFR (SQZ24) Quote - The Globe and Mail
Alumis looks to raise $300 million in IPO. Here’s what you need to know - AlphaStreet
Idiopathic Pulmonary Fibrosis Pipeline Analysis 2024: FDA Approval, Clinical Trials, Therapies, MOA, ROA by - EIN News
The Role of Horseshoe Crabs in the Biomedical Industry and Recent Trends Impacting Species Sustainability - Frontiers
Investing in Ocean Biomedical Inc. (OCEA) might be an excellent idea, but the stock is currently overvalued ... - US Post News
Best Penny Stocks for Today (Charts Updated Daily) • Benzinga - Benzinga
Biotech Stock Roundup: ZGNX's Acquisition News, REGN, BLUE's Updates & More - Yahoo Lifestyle UK
Biotech Stocks: The Top 5 To Watch As Shares Broadly Struggle - Investor's Business Daily
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace
TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail
Stocks Fall Before CPI Report and FOMC Meeting - The Globe and Mail
Stocks Settle Higher Ahead of the Tue/Wed FOMC Meeting - The Globe and Mail
Ocean Biomedical congratulates joint venture partner Virion TherapeuticsTipRanks.com - TipRanks
Tempus AI gears up for IPO. Here’s everything you need to know - AlphaStreet
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive ... - GlobeNewswire
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024 - ForexTV.com
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024 - GlobeNewswire Inc.
Virion Therapeutics Reports Positive First-in-human, First-in-class, Phase 1b Immunogenicity Data of VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure at EASL Congress - PR Newswire
Virion Therapeutics Reports Positive First-in-human, First-in-class, Phase 1b Immunogenicity Data of VRON-0200, a ... - PR Newswire
Stocks Climb on Positive Corporate News - The Globe and Mail
Ocean Biomedical receives notice of non-compliance from NasdaqTipRanks.com - TipRanks
Ocean Biomedical Faces Nasdaq Non-Compliance Notice and DelaysTipRanks.com - TipRanks
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form ... - GlobeNewswire
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - GlobeNewswire Inc.
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - Yahoo Finance
Stocks Mixed in TodayAfternoon Trade - Nasdaq
Ratio Review: Analyzing Ocean Biomedical Inc. (OCEA)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex
OCEA Stock Earnings: Ocean Biomedical Reported Results for Q3 2023 - InvestorPlace
Ocean Biomedical Inc.’s Shares Reel: 189.95% Quarterly Revenue Decline Amid 60.29M Market Cap - The InvestChronicle
Market Insight: Ocean Biomedical Inc. (OCEA)'s Notable Gain, Closing at 1.74 – DWinneX - The Dwinnex
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential ... - Markets Insider
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential ... - BioSpace
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease - ForexTV.com
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential - Daily Guardian Canada
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential ... - GlobeNewswire
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential ... - Nasdaq
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease - BioSpace
Ocean Biomedical Inc. (OCEA) Stock: Uncovering 52-Week Market Trends – Invest Chronicle - The InvestChronicle
Why Is Helius Medical Technology (HSDT) Stock Up 47% Today? - InvestorPlace
RI biotech that's overdue on annual report told it's out of compliance by Nasdaq - The Business Journals
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K - GlobeNewswire Inc.
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K - Yahoo Finance
Why Is Palisade Bio (PALI) Stock Up 57% Today? - InvestorPlace
PACS Group gears up for $400 million IPO. Here’s all you need to know - AlphaStreet
Femasys is committed to providing women with revolutionary healthcare products: CEO - AlphaStreet
Russell 2000 index best and worst performing stocks of 2024 - Invezz
Largest borrow rate increases among liquid names - TipRanks
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL - GlobeNewswire Inc.
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL - GlobeNewswire
大文字化:
|
ボリューム (24 時間):